#1
#1 out of 1
health6h ago
‘Problematic precedent’: expert says Australia could be next as UK agrees to pay 25% more for new US medicines
- The UK will pay 25% more for new US medicines under a recent deal, prompting concern from health experts about funding NHS services.
- Australia’s PBS remains central as officials say they won’t compromise access to affordable medicines while engaging with the US on pricing dynamics.
- Experts warn the deal could set a precedent affecting global medicine pricing and threaten funding for health services in other countries.
- Australian experts say the deal could lead to pressure to approve more high-cost drugs that may not meet value-for-money standards.
- Experts say the implications are global and that Australia should monitor the UK-US arrangement as it negotiates its own pricing framework.
- Medicines Australia urges reform of the Health Technology Assessment to speed access to new medicines while maintaining value.
- NHS funding concerns are tied to spending constraints on staff and proven treatments amid broader budget pressures.
- UK officials say the deal aims to shift global pharmaceutical policy, with the US hoping other countries follow.
- Australia’s Health Minister emphasizes PBS protections during ongoing discussions with US representatives.
Vote 0